Search Results for "Aveed"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Aveed. Results 1 to 3 of 3 total matches.
See also: testosterone

In Brief: Azmiro — A Single-Dose Injectable Formulation of Testosterone Cypionate

   
The Medical Letter on Drugs and Therapeutics • Mar 17, 2025  (Issue 1724)
643.10 100 mg/0.5 mL) Testosterone undecanoate – Aveed (Endo)7 3 mL vials (250 mg/mL) 750 mg IM at 0 ...
The FDA has approved Azmiro (Azurity), the first injectable formulation of testosterone cypionate to become available in single-dose vials and prefilled syringes for treatment of males with conditions associated with a deficiency or absence of endogenous testosterone. Injectable testosterone cypionate has been available in multidose vials (Depo-Testosterone, and generics) for many years. Testosterone enanthate (Xyosted) is available in prefilled autoinjectors for use in adult men. No testosterone products are approved for treatment of low testosterone levels due solely to aging. All...
Med Lett Drugs Ther. 2025 Mar 17;67(1724):44-5   doi:10.58347/tml.2025.1724b |  Show IntroductionHide Introduction

Two New Oral Testosterone Products for Hypogonadism

   
The Medical Letter on Drugs and Therapeutics • Oct 31, 2022  (Issue 1662)
) Testosterone undecanoate – Aveed (Endo)6 3 mL vials (250 mg/mL) 750 mg IM at 0 and 4 weeks, 1557.60 then q10 ...
The FDA has approved two new oral formulations of testosterone undecanoate — Kyzatrex (Marius) and Tlando (Antares) — for treatment of males with a deficiency of endogenous testosterone due to conditions such as Klinefelter syndrome, orchiectomy, toxic damage from chemotherapy or alcohol, or pituitary-hypothalamic injury caused by tumors, trauma, or radiation. Jatenzo, another oral testosterone undecanoate formulation, was approved for the same indication in 2019. No testosterone products are approved for treatment of low testosterone levels due solely to...
Med Lett Drugs Ther. 2022 Oct 31;64(1662):172-4 |  Show IntroductionHide Introduction

Jatenzo - An Oral Testosterone for Hypogonadism

   
The Medical Letter on Drugs and Therapeutics • Jun 28, 2021  (Issue 1627)
Testosterone undecanoate – Aveed (Endo)6 3 mL vials (250 mg/mL) 750 mg IM at 0 and 4 weeks, 1416.80 then q10 ...
An oral formulation of testosterone undecanoate (Jatenzo – Clarus) has been approved by the FDA for treatment of adult men with conditions associated with a deficiency of endogenous testosterone, such as Klinefelter syndrome, orchiectomy, toxic damage from chemotherapy or alcohol, or pituitary-hypothalamic injury from tumors, trauma, or radiation. Jatenzo is not approved for treatment of low testosterone levels solely due to aging. It is the first oral testosterone formulation to be approved in the US.
Med Lett Drugs Ther. 2021 Jun 28;63(1627):103-4 |  Show IntroductionHide Introduction